
Sakditad Saowapa/X
Jun 5, 2025, 10:57
Sakditad Saowapa: Excited to share our abstract on Proton pump inhibitors in HCC published in JCO
Sakditad Saowapa, Oncologist at UI Holden Comprehensive Cancer Center, shared a post on X:
“Excited to share our abstract published in JCO!
PPIs in HCC = higher risks even after PSM.
- Mortality: HR 1.18
- DVT: HR 1.73 | PE: HR 1.96
- GIB: HR 4.43 | HE: HR 3.26
- SBP: HR 3.33 | Acute liver failure: HR 3.20
- Global dataset | 57k+ pts
Honored to be part of this amazing team!”
Proton pump inhibitors and clinical outcomes in hepatocellular carcinoma patients: A propensity score–matched analysis from a global federated dataset.
Authors: Natchaya Polpichai, Sakditad Saowapa, Shu-Yen Chan, Manasawee Tanariyakul, Chanakarn Kanitthamniyom, Andrea Ortiz Maldonado, Chanokporn Puchongmart, Nattanicha Chaisrimaneepan, Miriam Paz Sierra, Phuuwadith Wattanachayakul, Rawipan Uaratanawong, Pharit Siladech, and Lukman Aderoju Tijani.
You can read the full article on Journal of Clinical Oncology.
More posts featuring Sakditad Saowapa.
Andrea Ortiz Maldonado
cancer
Chanakarn Kanitthamniyom
Chanokporn Puchongmart
fight against cancer
Global fight against cancer
HCC
hepatocellular carcinoma
JCO
Lukman Aderoju Tijani
Manasawee Tanariyakul
Miriam Paz Sierra
Natchaya Polpichai
Nattanicha Chaisrimaneepan
OncoDaily
Oncology
Pharit Siladech
Phuuwadith Wattanachayakul
PPIs
Proton pump inhibitors
Rawipan Uaratanawong
Sakditad Saowapa
Shu-Yen Chan
UI Holden Comprehensive Cancer Center
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 5, 2025, 10:31
Jun 5, 2025, 10:07
Jun 5, 2025, 10:04
Jun 5, 2025, 09:56